Blue Chip Stocks Healthcare Stocks Large Caps Life Sciences

Sick Charts: Why The ASX’s 3 Pathology Stocks Are All Under the Weather

The ASX's 3 pathology stocks: Sonic Healthcare (ASX:SHL), Healius (ASX:HLS) and Australian Clinical Labs (ASX:ACL); have delivered a torrid experience for shareholders over the past two to three years. Sonic, the…

ByNick Sundich

22

Dec 2023

Uncategorized

Why has the proposed Healius ACL merger failed and what lies next for both companies?

The Healius ACL merger appears all but dead now that the ACCC blocked the plans. Even so, it was on shaky grounds long before the competition regulator showed its scepticism…

ByNick Sundich

27

Feb 2023

Uncategorized

Ageing population stocks are set to derive significant long-term value

Ageing population stocks represent among the best long-term opportunities that exist for investors. Over the next 25 years, the world's population of people over 60 will double. Looking specifically at Australia, the…

ByNick Sundich

Sick Charts: Why The ASX’s 3 Pathology Stocks Are All Under the Weather

Why has the proposed Healius ACL merger failed and what lies next for both companies?

Ageing population stocks are set to derive significant long-term value

Investing in the Year of the Rat

2020, the Golden Year

Market trouble spots to avoid in 2020

Sick Charts: Why The ASX’s 3 Pathology Stocks Are All Under the Weather

Why has the proposed Healius ACL merger failed and what lies next for both companies?

Ageing population stocks are set to derive significant long-term value

Investing in the Year of the Rat

2020, the Golden Year

Market trouble spots to avoid in 2020

Add Your Heading Text Here